Financials Aclarion, Inc.

Equities

ACON

US6551872012

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2024-05-22 EDT 5-day change 1st Jan Change
0.334 USD +7.74% Intraday chart for Aclarion, Inc. +20.14% -89.56%

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 4.536 1.759 2.74 -
Enterprise Value (EV) 1 4.536 1.759 2.74 2.74
P/E ratio -0.44 x - -0.47 x -1.28 x
Yield - - - -
Capitalization / Revenue 75.1 x 23.3 x 44.2 x 13.7 x
EV / Revenue 75.1 x 23.3 x 44.2 x 13.7 x
EV / EBITDA - - - -
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 489 550 8,204 -
Reference price 2 9.280 3.200 0.3340 0.3340
Announcement Date 23-02-27 24-02-21 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025
Net sales 1 - 0.0604 0.0754 0.062 0.2
EBITDA - - - - -
EBIT 1 - -6.099 -4.876 -4.928 -5.119
Operating Margin - -10,090.21% -6,466.82% -7,948.39% -2,559.5%
Earnings before Tax (EBT) 1 - -7.606 -4.911 -4.928 -5.119
Net income 1 -4.95 -7.606 -4.911 -6.652 -6.205
Net margin - -12,583.62% -6,513.75% -10,729.03% -3,102.5%
EPS 2 -14.08 -20.96 - -0.7100 -0.2600
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 22-03-04 23-02-27 24-02-21 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 0.0107 0.0182 0.0225 0.0255 0.0171 - 0.0101 0.015 0.017 0.02
EBITDA - - - - - - - - - -
EBIT 1 -2.365 -1.633 -1.327 -1.181 -1.406 - -1.275 -1.226 -1.214 -1.212
Operating Margin -22,147.94% -8,964.11% -5,891.47% -4,637.85% -8,237.84% - -12,614.34% -8,173.33% -7,141.18% -6,060%
Earnings before Tax (EBT) 1 -3.708 -1.633 -1.329 -1.183 -1.465 - -2.399 -1.226 -1.214 -1.212
Net income 1 -3.836 -1.633 -1.329 -1.183 -1.465 -0.998 -2.399 -1.526 -1.514 -1.212
Net margin -35,914.98% -8,962.84% -5,901.02% -4,646.49% -8,579.73% - -23,729.97% -10,173.33% -8,905.88% -6,060%
EPS 2 -7.840 -3.360 -1.600 -2.400 -2.880 -1.920 -0.4400 -0.1500 -0.0700 -0.0600
Dividend per Share - - - - - - - - - -
Announcement Date 22-08-15 22-11-14 23-02-27 23-07-03 23-08-25 23-11-14 24-05-15 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share - - - - -
Cash Flow per Share - - - - -
Capex - - - - -
Capex / Sales - - - - -
Announcement Date 22-03-04 23-02-27 24-02-21 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.334 USD
Average target price
1.5 USD
Spread / Average Target
+349.10%
Consensus
  1. Stock Market
  2. Equities
  3. ACON Stock
  4. Financials Aclarion, Inc.